John A. Lewicki, EVP & Chief Scientific Officer at OncoMed Pharmaceuticals Inc (OMED), sold 4,602 shares at $20.45 ($82K) on 2014-11-03, disclosed to the SEC on 2014-11-05.
Scheduled sale ($82k) by EVP & Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 602 | $0 | 0.0% |
| 2 | $20.45 | 4,000 | $82K | 100.0% |
| Total | $17.77 avg | 4,602 | $82K | 100% |
| Filing → |
| OMED | SELL | 2018-10-11 | $2K | — | Filing → |
| OMED | SELL | 2018-10-10 | $5K | — | Filing → |
| OMED | SELL | 2018-04-26 | $12K | — | Filing → |